When Alexander Flemming discovered a mold on a culture plate overgrown with bacteria in 1928, he did not expect to find one of the most widely used active substances: penicillin. Accidental discoveries and the identification ...
Biochemistry
Jul 22, 2021
0
286
(PhysOrg.com) -- Scientists from Imperial College London and Diamond Light Source have revealed the structure of a cholesterol-lowering-drug target. Published in the journal Nature, this finding could lead to much more effective ...
Biochemistry
Oct 6, 2011
0
0
A needle-in-the-haystack search through nearly 390,000 chemical compounds had led scientists to a substance that can sneak through the protective barrier surrounding the brain with effects promising for new drugs for Parkinson's ...
Biochemistry
Apr 20, 2011
0
0
Using a sophisticated technique of x-ray crystallography, researchers Xiaohu Mei, PhD, and David Atkinson, PhD, from Boston University School of Medicine (BUSM) have for the first time obtained an "image" of the structure ...
Biochemistry
Nov 4, 2011
0
0
The biggest U.S.-based drugmaker will change leaders in January when Pfizer Chief Operating Officer Albert Bourla replaces CEO Ian Read, who has led the company for nearly eight years.
Business
Oct 1, 2018
0
4
Contrary to common perception, state and local police are often on the front lines against product counterfeiting, yet it's unclear how prepared they are to deal with the growing crime, according to a new report from two ...
Social Sciences
Feb 22, 2012
0
0
A US appeals court on Wednesday temporarily suspended an order blocking the French pharmaceutical group Sanofi and its American partner Regeneron from selling their anti-cholesterol drug Praluent.
Medications
Feb 9, 2017
0
5
